Sign In
Buy GNMSF
$232.50
+0.160 (+0.0688%)
At Close: Jun 03, 2026
Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript
08:43am, Thursday, 14'th May 2026
Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript
Genmab A/S (OTCMKTS:GNMSF) Stock Price Crosses Below 200 Day Moving Average – Here’s Why
03:56am, Thursday, 12'th Mar 2026
Genmab A/S (OTCMKTS:GNMSF - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $305.26 and traded as low as
Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
02:52pm, Wednesday, 11'th Mar 2026
Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
04:14pm, Tuesday, 17'th Feb 2026
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
10:30pm, Thursday, 29'th Jan 2026
From a sector perspective, strength within Industrials and Information Technology offset relative weakness in Health Care. The October earnings report reinforced confidence in Comfort Systems' ability
Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
12:05am, Wednesday, 14'th Jan 2026
Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript
04:22pm, Thursday, 11'th Dec 2025
Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript
Genmab A/S (GMAB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
02:28pm, Thursday, 04'th Dec 2025
Genmab A/S (GMAB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Genmab A/S (GMAB) Presents at Jefferies London Healthcare Conference 2025 Transcript
07:23am, Saturday, 22'nd Nov 2025
Genmab A/S (GMAB) Jefferies London Healthcare Conference 2025 November 19, 2025 7:00 AM EST Company Participants Jan van de Winkel - Co-Founder, President & CEO Anthony Pagano - Executive VP & CFO Con
Genmab A/S (GMAB) Q3 2025 Earnings Call Transcript
06:46am, Saturday, 08'th Nov 2025
Genmab A/S (GMAB) Q3 2025 Earnings Call November 6, 2025 12:00 PM EST Company Participants Jan van de Winkel - Co-Founder, President & CEO Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head
Genmab A/S (GMAB) M&A Call Transcript
05:47pm, Monday, 29'th Sep 2025
Genmab A/S (GMAB) M&A Call September 29, 2025 7:00 AM EDT Company Participants Jan van de Winkel - Co-Founder, President & CEO Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head of Experimen
Genmab A/S (GMAB) Presents at Bank of America Global Healthcare Conference 2025 Transcript
03:17am, Thursday, 25'th Sep 2025
Genmab A/S (GMAB) Bank of America Global Healthcare Conference 2025 September 23, 2025 6:35 AM EDT Company Participants Anthony Pagano - Executive VP & CFO Conference Call Participants Sachin Jain - B
Genmab A/S (GMAB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
06:41pm, Tuesday, 09'th Sep 2025
Genmab A/S (GMAB) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT Company Participants Jan van de Winkel - Co-Founder, President & CEO Anthony Pagano - Executive
Genmab A/S (GMAB) Q2 2025 Earnings Call Transcript
08:18pm, Thursday, 07'th Aug 2025
Genmab A/S (GMAB) Q2 2025 Earnings Conference Call August 7, 2025 12:00 PM ET Company Participants Anthony Pagano - Executive VP & CFO Brad Bailey - Corporate Participant Jan G.J. van de Winkel - Co-F
Genmab A/S (GMAB) Q4 2024 Earnings Conference Call Transcript
09:32am, Friday, 14'th Feb 2025
Genmab A/S (GMAB) Q4 2024 Earnings Conference Call February 12, 2025 12:00 PM ET Company Participants Jan van de Winkel - CEO Brad Bailey - EVP and Chief Commercial Officer Anthony Pagano - CFO Tahamt
